A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity

Summary

The main purpose of the study is to measure and compare the effects of eloralintide and placebo on insulin sensitivity (how your body responds to insulin), metabolic health (things like sugar and cholesterol), and body weight in participants with obesity or overweight. For each participant, the study will last about 35 weeks and include 3 in patient visits totaling 7 days.

Timeline

Start

2026-06-24

Primary completion

2027-08

Completion

2027-08

Drugs

Indications